Table 1.
Study | Tick strain | Daya | Placebob | Simparica Trio™b | % Efficacy | Test statistic | ||
---|---|---|---|---|---|---|---|---|
Mean | Range | Mean | Range | |||||
1 | Bertek Inc.c | 2 | 19.0 | 3–32 | 0 | 0–0 | 100 | t(18) = 6.24, P < 0.0001 |
7 | 23.1 | 14–38 | 0 | 0–0 | 100 | t(18) = 10.08, P < 0.0001 | ||
14 | 20.7 | 13–33 | 0 | 0–0 | 100 | t(18) = 9.10, P < 0.0001 | ||
21 | 23.1 | 14–37 | 0 | 0–0 | 100 | t(18) = 9.12, P < 0.0001 | ||
28 | 20.9 | 13–29 | 0.1 | 0–1 | 99.5 | t(18) = 10.05, P < 0.0001 | ||
35 | 29.7 | 20–44 | 0.1 | 0–1 | 99.7 | t(18) = 13.08, P < 0.0001 | ||
2 | Ecto Services Incd | 3 | 17.7 | 12–27 | 0.1 | 0–1 | 99.4 | t(9.06) = 10.07, P < 0.0001 |
8 | 23.7 | 12–35 | 0.1 | 0–1 | 99.6 | t(9.06) = 10.10, P < 0.0001 | ||
15 | 16.1 | 5–25 | 0 | 0–0 | 100 | t(9) = 9.11, P < 0.0001 | ||
22 | 13.9 | 7–23 | 0 | 0–0 | 100 | t(9) = 9.80, P < 0.0001 | ||
29 | 12.4 | 9–16 | 0.2 | 0–1 | 98.4 | t(9) = 16.78, P < 0.0001 | ||
36 | 14.4 | 4–25 | 0.1 | 0–1 | 99.3 | t(9.05) = 7.32, P < 0.0001 |
aFirst infestation on Day -2. Subsequent infestations on Day 5, 12, 19, 26 and 33. Tick counts were conducted at 48 (Study 1) or 72 (Study 2) hours post-treatment and subsequent re-infestation
bTreatment with placebo or Simparica Trio™ (minimum dose 1.2 mg/kg sarolaner, 24 µg/kg moxidectin and 5 mg/kg pyrantel (as pamoate salt)) occurred on Day 0
cColony originated from ticks field-collected in Greenbrier, AR, USA, in 2009 and was last supplemented with wild-caught ticks ~ 3 years prior to study start
dColony originated from ticks field-collected in Stillwater, OK, USA, in 2011 and was last supplemented with field-collected ticks ~ 4 months prior to study start